MEG3 and diabetes mellitus: The downregulated MEG3 levels in DM reduce the expression of transcription factors musculoaponeurotic fibrosarcoma oncogene family protein A (MAFA) and pancreatic and duodenal homeobox 1 (PDX1), which in turn inhibit insulin synthesis and secretion from the pancreatic β-cells [191].